G6PD Deficiency in the Gulf: Why Screening Matters Before Peptide and IV Therapy
G6PD deficiency is a common inherited red cell condition across the Gulf and wider Middle East. This article explains the known triggers, why status is checked before IV nutrient therapy, and how the test is interpreted.
By The Protocols Company Research Desk
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common inherited enzyme conditions in the world. It is reported across the Gulf, the wider Middle East, Africa, the Mediterranean and South Asia, and estimates of how many people carry it vary by population. Most carriers never have symptoms and many never find out. It matters in a clinic setting because the underlying vulnerability, red cells that cope poorly with oxidative stress, can be unmasked by certain medicines, infections and foods.
What the enzyme does
G6PD sits in the pentose phosphate pathway. In red cells it is the main source of NADPH, which keeps glutathione in its reduced form and helps protect haemoglobin from oxidative damage. Red cells have no nucleus and cannot make fresh enzyme, so a deficiency leaves them with very little reserve. Under enough oxidative load they can break down early, a process called haemolysis. The variants are common in part because they appear to offer some protection against malaria.
The gene sits on the X chromosome, so the condition is more often clinically apparent in males. Women with one altered copy can have a patchy, variable picture because of random X inactivation, which is why a single normal-looking result in a woman does not always settle the question.
Most people with G6PD deficiency are well. The risk lies in what is added to the system, not in the baseline.
Known triggers
Research and clinical experience point to a recurring set of triggers. Severity depends on the specific variant, and many people with a mild variant tolerate several of these without difficulty.
- Fava beans (broad beans), the classic trigger known as favism
- Certain antimalarial and anti-infective drugs, including primaquine, dapsone and some sulfonamides
- Rasburicase and high-dose methylene blue, used in hospital settings
- Acute infections, which are among the most common triggers in practice
- High-dose intravenous vitamin C, where haemolysis has been reported in deficient patients, which is why screening is standard practice before such infusions
That variation between variants is why an individual history carries more weight than any generic list.
What this means for peptide therapy
To our knowledge, there is no established evidence that commonly used research peptides cause haemolysis in G6PD deficiency, and the clinical literature on the question is thin. That is a gap in the data rather than a reassurance. A cautious physician therefore treats G6PD status as part of the wider safety picture.
- Confirming status before any intravenous nutrient infusion
- Reviewing the full medicine list for known oxidant drugs
- Asking about a personal or family history of anaemia, jaundice or a reaction to fava beans
- Advising patients to report dark urine, new yellowing of the skin or eyes, or unexplained fatigue after starting any new product
Supplements deserve the same attention. Very high doses of redox-active compounds are a reason to pause and check, particularly in someone with a family history of the condition.
Testing and its pitfalls
Diagnosis uses a quantitative G6PD enzyme assay on a blood sample. Timing matters. During or soon after an episode of haemolysis, or after a transfusion, younger red cells with higher enzyme activity can push the result into the normal range. A repeat test several weeks later may then be needed.
Results are read alongside the full blood count and, where relevant, the reticulocyte count and bilirubin. If you already have a result from a hospital admission, an employer medical or earlier screening, bring it with you. It can save a repeat test and shortens the review.
If you're exploring G6PD screening as part of your protocol, our clinical team can review your case. Take the 2-minute quiz at /find-my-stack or book a free consultation at /book.
